CL V2 - Promotions - Title

Article

Promotions

Newsletter

Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.

Subscribe Now!
Recent Videos
Related Content
Novel Plasma Assays That Selectively Detect Tau Characteristics Will Refine Clinical Study of Alzheimer Disease / image credit Courtesy of C2N Diagnostics

Novel Plasma Assays That Selectively Detect Tau Characteristics Will Refine Clinical Study of Alzheimer Disease

Grace Halsey
August 8th 2025
Article
The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

The Weekly Dose: Pediatric Vaccine Safety, Atopic Dermatitis, Dementia Risk, and Maternal Depression

Sydney Jennings
August 8th 2025
Podcast
Lilly's Oral GLP-1 Agonist Orforglipron Linked to Weight Reduction of 12.4% in Pivotal Phase 3 Trial / image credit ©MichaelVI/stock.adobe.com

Lilly's Oral GLP-1 Agonist Orforglipron Linked to Weight Reduction of 12.4% in Pivotal Phase 3 Trial

Grace Halsey
August 8th 2025
Article
Make It Routine: Screening for Cognitive Decline in Primary Care

Make It Routine: Screening for Cognitive Decline in Primary Care

Anna Chodos, MD, MPH;Sydney Jennings
August 8th 2025
Podcast
Fremenazumab Label Expanded for Treatment of Episodic Migraine in Children Aged 6 to 17 Years

Fremenazumab Label Expanded for Treatment of Episodic Migraine in Children Aged 6 to 17 Years

Grace Halsey
August 8th 2025
Article
Investigational Antidepressant BH-200 Shows Benefit in Phase 2b Trial for MDD / Image credit: ©Srdjan/AdobeStock

Investigational Antidepressant BH-200 Shows Benefit in Phase 2b Trial for MDD

Sydney Jennings
August 8th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.